Medicine News and Research

RSS

Study reveals the long-term neurologic consequences of COVID-19

If you've had COVID-19, it may still be messing with your brain. Those who have been infected with the virus are at increased risk of developing a range of neurological conditions in the first year after the infection, new research shows.

22 Sep 2022

Researchers receive $3.4 million NIH grant to assess soccer's tradeoffs with respect to brain health

More than 25 million Americans play soccer, the world's most popular sport. Soccer significantly benefits brain health by boosting aerobic capacity and oxygen and blood flow to the brain, but it also has a downside: Recent studies show that highly repetitive heading of the ball is associated with structural brain changes and worse cognitive performance similar to brain damage caused by concussion.

22 Sep 2022

Lessons from South Korea's vaccination initiative can help cultivate planetary health action

South Korea had administered more COVID-19 vaccine doses per 100 people than other developed countries by the end of March 2022.

22 Sep 2022

KHN’s ‘What the Health?’: Biden declares the pandemic ‘over’

President Joe Biden's declaration in a national interview that the covid-19 pandemic is "over" has complicated his own administration's efforts to get Congress to provide more funding for treatments and vaccines, and to get the public to go get yet another booster.

22 Sep 2022

Study shows increase in depression cases between 2015 and 2020

In a new study, researchers explored the trends in the prevalence of depression from 2015 to 2020.

22 Sep 2022

UCLA scientists receive $10 million to shed light on the developing brain's cellular infrastructure

Two scientists at the David Geffen School of Medicine at UCLA have been awarded nearly $10 million from the National Institutes of Health's Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative for research projects that aim to shed light on the developing brain's cellular infrastructure to better understand brain disorders.

22 Sep 2022

UN, WHO Primary Health Care Award recognizes Lesotho-Boston Health Alliance’s achievements in primary care

An innovative program between Boston University School of Medicine's (BUSM) department of family medicine and the Lesotho Ministry of Health is being honored today by the United Nations (UN) at the annual meeting of the Friends of the UN Inter-Agency Task Force on the Prevention and Control of Non-Communicable Diseases.

22 Sep 2022

Artificial intelligence tools speed up the process of identifying people who inject drugs

An automated process that combines natural language processing and machine learning identified people who inject drugs (PWID) in electronic health records more quickly and accurately than current methods that rely on manual record reviews.

22 Sep 2022

Vizient recognizes NYU Langone Health as No. 1 in quality and safety for inpatient, ambulatory care

NYU Langone Health has been recognized as No. 1 in quality and safety for inpatient and ambulatory care by Vizient, Inc.

22 Sep 2022

New board members bring significant leadership experience in the biotech sector

Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat disease, is pleased to announce the appointment of three new members to its Board of Directors: Dr. Nancy Krieger, Dr. Don Haut, and Dr. Devyn Smith.

From Aspect Biosystems 22 Sep 2022

Scientists uncover key details of an immune-cell process that underlies excessive inflammation

A team led by Scripps Research scientists has uncovered key details of an immune-cell process that frequently underlies excessive inflammation in the body.

22 Sep 2022

New modeling system identifies potential therapeutics for autosomal recessive polycystic kidney disease

Organoids - lab grown cells or tissues that resemble organs - serve as a new tool for disease modeling, but researchers often have difficulty replicating the biophysical conditions in which the organs operate within the body.

22 Sep 2022

Most people infected with SARS-CoV2 recover within 12 months, study finds

A McMaster University-led study has found that most people infected with the SARS-CoV2 virus recover within 12 months, irrespective of the severity.

22 Sep 2022

Human gene variant in ADHD, autism exposes sex-dependence of neuronal signaling mechanisms

The prevalence, age of onset, and clinical symptoms for virtually all neuropsychiatric disorders differ between men and women. Among the disorders with pronounced sex bias are Attention-Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD), where the ratio of males/females diagnosed is approximately 4 to 1.

21 Sep 2022

Medicine News and Research

Study reveals the long-term neurologic consequences of COVID-19

Researchers receive $3.4 million NIH grant to assess soccer's tradeoffs with respect to brain health

Lessons from South Korea's vaccination initiative can help cultivate planetary health action

KHN’s ‘What the Health?’: Biden declares the pandemic ‘over’

Study shows increase in depression cases between 2015 and 2020

UCLA scientists receive $10 million to shed light on the developing brain's cellular infrastructure

UN, WHO Primary Health Care Award recognizes Lesotho-Boston Health Alliance’s achievements in primary care

Artificial intelligence tools speed up the process of identifying people who inject drugs

Vizient recognizes NYU Langone Health as No. 1 in quality and safety for inpatient, ambulatory care

New board members bring significant leadership experience in the biotech sector

Scientists uncover key details of an immune-cell process that underlies excessive inflammation

New modeling system identifies potential therapeutics for autosomal recessive polycystic kidney disease

Most people infected with SARS-CoV2 recover within 12 months, study finds

Human gene variant in ADHD, autism exposes sex-dependence of neuronal signaling mechanisms

Mount Sinai researchers use unbiased AI-based method to study the causes of cognitive impairment

New genetically-targeted MND therapy could be a turning point for patient care

Global burden of type 1 diabetes likely to double by 2040, study predicts

Cardiovascular disease risk factors are largely the same for women and men, study shows

Medulloblastomas originate much earlier in pregnancy than previously thought and may be preventable

Better physical fitness reduces frailty risk in patients with chronic lymphocytic leukemia

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News